New weapon tested in fight against Tough-to-Treat cancers
Disease control
Recruiting now
This study is testing a new drug called DT-7012 for people with advanced solid tumors that have spread or returned after other treatments. The main goals are to find a safe dose and see if the drug, given alone or with an immunotherapy, can help control the cancer. It is an early…
Phase: PHASE1, PHASE2 • Sponsor: Domain Therapeutics Australia Pty Ltd • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC